ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.
Pharmabiz7h
New norms for nasal spray of ASU drugs to bring in uniformity in composition & efficacy: Experts
Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...
WTEN16h
Albany Library to host a number of Narcan trainings
Albany Library is hosting several Narcan trainings in the coming months. With at least one monthly training, the community ...
Livestrong.com on MSN17h
Phenylephrine for Colds: Why It Doesn’t Work and What You Should Use Instead
Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...
Green Matters17h
Viral Video Reveals the Right Way to Use Flonase, Because Apparently We're All Doing It Wrong
A doctor explains how to correctly use Flonase nasal spray, which includes manually opening your sinuses before you spray.
Drug Store News18h
Lupin receives FDA nod for generic Atrovent
Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or ...
Hydreight Technologies Expands Telehealth Offerings with Launch of NAD+ Therapy on VSDHOne Platform
NAD+ IonToPatch – Utilizing iontophoresis, a non-invasive transdermal drug delivery system that uses a voltage gradient to increase skin permeability, allowing for effective NAD+ absorption. The latex ...